Stay updated on Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial
Sign up to get notified when there's something new on the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page.

Latest updates to the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page
- Check5 days agoChange DetectedDifference0.7%
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check20 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.5%
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.8%
- Check34 days agoChange DetectedThe page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference1%
- Check41 days agoChange DetectedThe webpage has updated the study details for Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in treating Non-Hodgkin Lymphoma, including new results reporting dates and changes in survival metrics, with a focus on longer follow-up periods and updated patient response rates.SummaryDifference20%
Stay in the know with updates to Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page.